ICVAX
Alternative Names: HIV therapeutic DNA vaccine - Immuno Cure; IMC-001 - Immuno CureLatest Information Update: 23 Feb 2024
At a glance
- Originator Immuno Cure
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I HIV-1 infections
Most Recent Events
- 15 Feb 2024 Immuno Cure has patent protection for PD-1-Enhanced DNA vaccine platform Worldwide
- 14 Feb 2024 Phase-I clinical trials in HIV-1 infections (Treatment-experienced) in China (IM) (NCT06253533)
- 17 Mar 2022 Immunogenicity data from a preclinical trial in HIV 1 infections released by Immuno Cure